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Abstract Inactivation of SV40 large T antigen in cells immor- 
talized with conditional mutants leads to activation of p53 and 
apoptosis. We have analysed during this process the expression 
of genes induced by p53 or differentially expressed uring apop- 
tosis in other systems. We find an early induction of WafllCipl. 
We also observe clusterin is induced during the process and dis- 
plays a high level of expression in non-apoptotic ells, suggesting 
a protective role for clusterin. Other genes associated with thy- 
mocyte and lymphocyte apoptosis are not induced, showing that 
the pattern of gene induction is specific to the system studied. 
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I. Introduction 
Apoptosis is an active process of gene-directed cellular self- 
destruction and in most cases serves a biologically meaningful 
homeostatic function [1-4]. It has been previously observed 
that rodent embryo cells conditionally immortalized by temper- 
ature-sensitive mutants of SV40 large T antigen undergo apop- 
tosis at restrictive temperature [5,6]. Apoptosis of these cells in 
restrictive conditions appears to be mediated by the release of 
wild-type p53 from large T antigen as judged by coprecipitation 
experiments and its ability to induce mdm-2 expression [5]. We 
have chosen one of these cell lines, called REtsAF, as a model 
system for studying p53-mediated apoptosis. 
We have observed that although global transcription and 
translation rates are only slightly affected by the induction of 
apoptosis in these cells, some proteins are differentially synthe- 
sized [7]. This suggests that, as in other cases of apoptosis, some 
genes are differentially expressed uring REtsAF apoptosis. In 
this report, we examine in apoptotic REtsAF cells the expres- 
sion of genes known to be regulated uring apoptosis of other 
cells. Parallel experiments performed with the REtsAF-Revl 
variant which is no longer temperature-sensitive andwith a cell 
line (RELPB) immortalized by wild-type SV40 [8] allowed us 
to distinguish effects of the temperature shift from apoptosis- 
related changes. 
2. Materials and methods 
2.1. Cell lines and cell culture 
The REtsAF and RELPB cell lines were isolated at low cell density 
from a rat embryo fibroblast culture infected with SV40 [8]. REtsAF 
*Corresponding author. Fax: (33) (1) 69 82 31 50. 
E-mail: Mignotte@cgrnvax.cgrn.cnrs-gif. f  
was obtained using a tsA58 mutant and is temperature-sensitive for 
immortalization while RELPB was obtained with wild-type SV40 and 
is immortal at both 33 and 39.5°C. REtsAF-Revl was derived from 
REtsAF by selection for proliferation at 39.5°C [7]. Cells were p opa- 
gated in Dulbecco's modified Eagle's medium (DMEM) supplemented 
with 10% fetal calf serum or DMEM/F12 supplemented with 2% ul- 
troser G, plus penicillin (100/2g/ml) and streptomycin (100 U/ml) under 
5% CO> The cultures were screened regularly for the absence ofmyco- 
plasma. 
2.2. RNA analysis 
Total cellular RNA was isolated from cells by the method of 
Chirgwin et al. [9]. Gene expression was assayed by the Northern 
blotting analysis. 10 mg of total RNA was fractionated on 1% agarose- 
formamide gel and transferred to nylon membrane (HybondN, Amer- 
sham) according to [10]. Probes for calmodulin, chondroitin sulfate 
proteoglycan core protein, clusterin, ubiquitin and GAPDH were ob- 
tained, respectively, by labeling of the insert of plasmid p21, p8.5 [11], 
pSP64-60HE [12], pHUB14.38 [13] and pGAPD-13 [14], respectively, 
with [32p]dCTP by random primers using the megaprime-labeling sys-
tems (Amersham). Probes for RP8, glutathione S-transferase (made 
from plasmids pRP-8 [15], pGST2 [16]) were labeled with [32p]dCTP by 
PCR of pBluescript inserts. PCR-radiolabeling reactions (100/21) con- 
tained 10 ng of supercoiled plasmid template, 100 pmol of universals 
primers, 5 nmol each of three nucleotides dATP, dGTP and dTTP, 0.32 
nmol dCTP, 2.5/21 of [32p]dCTP (400 Ci/mmol) and 2.5 U ofTaq DNA 
polymerase (Bioprobe). PCR was carried out for 30 cycles as follows: 
94°C for 30 s for denaturing; 45°C for 1 min for annealing; and 72°C 
for 1 min for extension, followed by 1 cycle for extension at 72°C for 
5 min. Hybridization was carried out in 5 x SSPE, 0.5% SDS and 
5 × Denhardt's at 65°C. Washes were done twice in 2 × SSPE, 0.1% 
SDS at room temperature and twice for 15 min at 65°C in 1 SSPE, 0.1% 
SDS. 
3. Results 
3.1. Expression of  genes induced during apoptosis in other 
systems 
We have analysed uring apoptosis of REtsAF cell lines the 
expression of several genes known to be induced in different 
models of programmed cell death. Three types of genes were 
studied: (1) genes identified uring glucocorticoid-induced thy- 
mocyte apoptosis (RP-8) [11,15]; (2) during prostate regression 
and other cell-death processes (clusterin) [17]; and (3) during y 
irradiation-induced lymphocyte apoptosis [18] and insect mus- 
cle degeneration [19] (polyubiquitin). Fig. 1 shows the example 
of RP-8 [15] and clusterin [17]. Clusterin is induced 10 h after 
the shift-up to the restrictive temperature (39.5°C) whereas 
RP-8 is constituvely expressed. Table 1 summarizes the results 
obtained with various genes. The genes encoding calmodulin, 
chondroitin sulfate proteoglycan core protein, ubiquitin and 
glutathione S-transferase Yb 1, which are induced in apoptotic 
thymocytes or lymphocytes [11,18,20,21], are not induced dur- 
ing apoptosis of REtsAF. 
In order to determine if the induction of clusterin is specific 
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Fig. 1. Steady-state levels of RP-8 and clusterin mRNA during REtsAF 
apoptosis. Total cellular RNA prepared from REtsAF at various times 
after the shift to restrictive conditions were analysed by Northern blot- 
ting. Nylon membrane was probed successively with RP8 and clusterin 
probes. 
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Fig. 2. Expression of clusterin in various rat embryo cells. Total cellular 
RNA prepared from REtsAF at various times after the shift to restric- 
tive conditions were analysed byNorthern blotting. The same experi- 
ment was performed with different cells that do not undergo apoptosis 
at 39°C: REtsAF-Revl, a REtsAF variant hat is no longer tempera- 
ture-sensitive; RELPB, established by the wild-type SV40; REF pri- 
mary rat embryo fibroblasts. Northern blotting of total cellular RNA 
from REtsAF at various times after a heat-shock (15 min at 42°C) is 
also shown. Nylon membrane was probed succesively with clusterin, 
HSP70 and GAPDH probes. 
to apoptotic ells, we have analysed its expression during the 
shift from 33 to 39.5°C in non-conditional cell lines. Fig. 2 
shows that clusterin is expressed at a high constitutive l vel in 
the temperature-insensitive variant REtsAF-Revl as well as in 
RELPB and in primary cells. This result argues against a caus- 
ative role for clusterin in cell death. In order to determine if
clusterin induction could be due to a heat-shock response, REt- 
sAF cells grown at 33°C were keeped for 15 min at 42°C and 
then shifted-back to 33°C. In contrast o HSP70, which is 
indeed induced, clusterin is not. This result shows that induc- 
tion of clusterin during apoptosis i not related to a heat-shock 
effect. 
3.2. Expression of genes known to be induced by p53 
We have previously observed that mdm-2 is induced in REt- 
sAF after 24 h in restrictive conditions [5], suggesting that 
apoptosis i mediated by p53. The Wafl/Cipl gene is a potential 
mediator of p53 tumor suppression [22] that inhibits G1 cyclin- 
dependent kinases [23]. We analysed the level of Wafl/Cipl 
mRNA in REtsAF during apoptosis. An induction of the 
Wafl/Cipl gene is observed after 8 h in restrictive conditions 
(Fig. 3). Wafl/Cipl is not detected in the temperature-insensi- 
tive cell lines whatever the temperature. Thus, a specific induc- 
tion of Wafl/Cipl is observed, supporting the idea that Wafl/ 
Cipl coud be a mediator of p53 leading to REtsAF cell-growth 
arrest and apoptosis. 
4. Discussion 
A number of genes, induced uring apoptosis of thymocytes 
or lymphocytes, are not induced during apoptosis of REtsAF. 
This result may indicate some cell-type specificity in the pattern 
of gene induction. This pattern could also be specific to the 
apoptosis induction signal. Nevertheless, atleast 3 genes previ- 
ously found to be associated with apotosis or regulated by p53 
are induced during REtsAF apoptosis: clusterin, mdm-2 and 
Wafl /Cip l . 
Clusterin, also called TRPM-2 and SGP-2, is an early indica- 
tor of programmed cell death [17]. The product of this gene is 
a sulfated glycoprotein the function of which remains unclear. 
Since we found that clusterin also displays a high level of ex- 
pression in temperature-insensitive cells, it is probably not in- 
volved in the cell-death process itself. Rather, in agreement with 
other results [24,25], the high constitutive l vel of expression i  
REtsAF-Revl suggests a protective role for clusterin. Apopto- 
sis of REtsAF cells in restrictive conditions appears to involve 
the release of p53 activity [5]. Thus, we can ask whether the 
induction of clusterin is mediated by the transcriptional ctiva- 
tor function of p53. This hypothesis cannot be ruled out but 
seems unlikely according to the high constitutive l vel observed 
in temperature-insensitive cellsin which p53 is inactivated by 
large T antigen ([5] and data not shown). Furthermore, the 
conserved putative cis-element which appears to be the target 
for specific DNA-binding factors in the clusterin gene [26] does 
not look like a p53-binding site and a computer search in the 
clusterin gene sequence [27] does not reveal any p53-binding site 
in other parts of the gene (data not shown). 
The p53-inducible gene Wafl/Cipl is induced in REtsAF 
between 4 and 8 h after the temperature shift. This induction 
is more rapid than that of mdm-2, in agreement with the pro- 
Table 1 
Expression of genes indentified by their diffential expression during apoptosis 
Gene(s) Induced in Expression in REtsAF 
Calmodulin, chondroitin sulfate Glucocorticoids induced thymocyte apoptosis [11,20] Not detected 
proteoglycan core protein 
RP8 
Glutathione S-transferase Ybl 
Clusterin 
Ubiquitin 
Glucocorticoids or radiation induced thymocyte apoptosis [15] 
Prostate regression [32] and steroid induced lymphocyte apoptosis [21] 
Prostate regression and various other cell death process [17] 
Radiation-induced lymphocyte apoptosis [18] and insect muscles degeneration [19] 
Not induced 
Not induced 
Induced 
Not induced 
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Fig. 3. Expression of Wafl in various cells. Total cellular RNA pre- 
pared from REtsAF at various times after the shift to restrictive condi- 
tions were analysed by Northern blotting. The same experiment was 
performed with REtsAF-Revl; RELPB and REF. Nylon membrane 
was probed with a Wafl probes. 
posal that other factors are rate limiting for mdm-2 expression 
[28]. Induction of Wafl/Cipl suggest hat it could be at least 
involved in the arrest of DNA replication occurring in REtsAF 
after the shift up to the restrictive temperature [7]. However, 
it is not yet clear if it plays a direct role in apoptosis induction. 
We have observed that growth arrest induced at 33°C in REt- 
sAF by growth factor deprivation or antimitotic drugs (data 
not shown) leads to apoptosis. Thus, it is possible that growth 
arrest induced by Wafl/Cipl also participates in REtsAF apop- 
tosis induction. However in others systems, p53-dependent 
apoptosis can occur in the absence of transcriptional ctivation 
of p53-target genes [29], which suggest hat, in some cells, p53 
can mediate apoptosis by repressing survival genes. Recently, 
a reevaluation of the role of de novo protein synthesis in thy- 
mocyte apoptosis has also suggested that inhibitors of protein 
synthesis may delay apoptosis rather than prevent it [30], sug- 
gesting that some of the components of the apoptotic machin- 
ery are already present before apoptosis induction. However, 
the identification of the genes that are up- or downregulated 
during apoptosis remains of great interest. Indeed, at least three 
types of genes can be regulated uring apoptosis: inducers of 
apoptosis, effectors of apoptosis and genes the expression of 
which is modified as a cell response to physiological changes. 
Identification of these genes should give an insight into apopto- 
sis regulation and the successive biochemical events leading to 
cell death [4]. Further work is needed to identify these genes and 
to understand how the release of p53 from SV40 large T antigen 
leads to the biological and physiological changes occurring 
during the process [31]. 
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